Recent research has shown that dysregulation of the mechanistic target of rapamycin (mTOR) has a role in certain common kidney diseases, such as diabetic nephropathy (Mori et al., 2009; Lu et al., 2011) and polycystic kidney disease (Perico et al., 2016). Here, MTOR is linked to diabetic kidney disease.